| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a77f1d1244a0136e23a7a8922d2699e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate |
2019-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9487903b1c80a29a0d2469aac0748014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37c758a0694dac6e4fac7a046b88b569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dadb6df699b47a96854a1b05696ae91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8aa04a6956a754e53e7c735b8ae6137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_349a17bb6d744e5807c7bf1cd62feb9e |
| publicationDate |
2020-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-111868045-A |
| titleOfInvention |
Diacylglycerolide compound, method for producing the same, and immunostimulatory agent containing the same as an active ingredient |
| abstract |
Disclosed are a novel diacylglycerolide compound that promotes the migration of neutrophils to enhance immunity and inhibit infection, a preparation method thereof, and an immunostimulatory agent comprising the same as an active ingredient. The diacylglycerol lactone compound in this specification is represented by Chemical Formula 1. In Chemical Formula 1, R1 and R2 are independently fatty acid residues of 2 to 30 carbon atoms. |
| priorityDate |
2018-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |